Allantoin 2 % / benzethonium chloride 0.2 % / lidocaine hydrochloride 4 % Oral Gel
RxNorm 2566834

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2566834 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: allantoin 2 % / benzethonium chloride 0.2 % / lidocaine hydrochloride 4 % Oral Gel.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCD
Allantoin 0.02 mg/MG / benzethonium chloride 0.002 mg/MG / lidocaine hydrochloride 0.04 mg/MG Oral Gel
Primary clinical definition
AUI:12676592
View
PSN
Allantoin 2 % / benzethonium chloride 0.2 % / lidocaine hydrochloride 4 % Oral Gel
AUI:12676594
View
SY
Allantoin 2 % / benzethonium chloride 0.2 % / lidocaine hydrochloride 4 % Oral Gel
AUI:12676593
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCD

Semantic Clinical Drug (SCD):
Allantoin 0.02 mg/MG / benzethonium chloride 0.002 mg/MG / lidocaine hydrochloride 0.04 mg/MG Oral Gel
(Atom ID: 12676592)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
allantoin 0.02 MG/MG / benzethonium chloride 0.002 MG/MG / lidocaine hydrochloride 0.04 MG/MG Oral Gel
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2566834
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12676592
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCD
Semantic Clinical Drug (Ingredient + Strength + Dose Form)
Source Code
2566834
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN ACTIVATED
04/29/2025
Date the RxNorm atom was reactivated
RXN AI
{1010076} 142440
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1011842} 40036
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1540658} 508
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{1010076} 6387
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1011842} 1390
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1540658} 508
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH
0.02 MG/MG / 0.002 MG/MG (expressed as benzethonium chloride) / 0.04 MG/MG (expressed as lidocaine hydrochloride)
Available drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM
{1010076} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1011842} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1540658} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUG
US
Drug available for use in Humans
RXN OBSOLETED
02/24/2025
Date the RxNorm atom became obsolete
RXTERM FORM
Gel
The RxTerm dose form name for this drug
PSN

Prescribable Name (PSN):
Allantoin 2 % / benzethonium chloride 0.2 % / lidocaine hydrochloride 4 % Oral Gel
(Atom ID: 12676594)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
allantoin 2 % / benzethonium chloride 0.2 % / lidocaine hydrochloride 4 % Oral Gel
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2566834
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12676594
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
2566834
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SY

Synonym (SY):
Allantoin 2 % / benzethonium chloride 0.2 % / lidocaine hydrochloride 4 % Oral Gel
(Atom ID: 12676593)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
allantoin 2 % / benzethonium chloride 0.2 % / lidocaine hydrochloride 4 % Oral Gel
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2566834
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12676593
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
2566834
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.